Yuta is the founder and CEO of Accelerated Bio, a regenerative medicine company based in Philadelphia commercializing the human Trophoblast Stem Cell (hTSC). hTSCs are the earliest pre-implantation, pre-placental cells that can be sourced ethically from an ectopic pregnancy. These naïve cells can scale to 85 population doublings with natural immune privilege, making them the most ideal starting cell source for allogeneic cell & gene therapies. The hTSC platform has been awarded 53 patents, providing freedom-to-operate for partners looking for a clear pathway to commercialization.
Yuta is passionate about accelerating cell & gene therapies to advance healthy longevity. Accelerated Bio’s pipeline includes Parkinson’s Disease, Type 1 Diabetes, as well as Cell Senescence for longevity.
Yuta has dual B.A. degrees in economics and legal studies from the University of California, Berkeley. Yuta earned his MBA in 2009 from China Europe International Business School (CEIBS) in Shanghai, China and graduated with the Outstanding Graduate of the Year Award.